Oppenheimer & Co’s Crescent Capital BDC CCAP Stock Holding History
Bought
Maintained
Sold
Other funds holding CCAP
TCDRS
FNF
SLF
AM
BI
AC
Oppenheimer & Co's CCAP Position: Q1 2026 in Review
Oppenheimer & Co reduced its Crescent Capital BDC (CCAP) stake by 0.08% in Q1 2026, selling an estimated $643 and leaving 61,239 shares worth $744K. The position accounts for 0.01% of the portfolio, ranked #1010.
Oppenheimer & Co first reported a position in CCAP in Q1 2020 and has held it in 10 quarters since. The position peaked at $861K in Q4 2025. 85 funds tracked by Wall St. Rank hold CCAP as of Q1 2026.
- Oppenheimer & Co held 61,239 shares of Crescent Capital BDC worth $744K as of Q1 2026.
- Oppenheimer & Co sold 47 Crescent Capital BDC shares in Q1 2026, an estimated $643.
- Crescent Capital BDC made up 0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1010 holding.
- Oppenheimer & Co first reported a position in Crescent Capital BDC in Q1 2020 and has held it in 10 quarters since.
- Oppenheimer & Co's Crescent Capital BDC position peaked at $861K in Q4 2025.
- 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.